Cargando…
Tissue engineered aortic valve
Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended dura...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDIMES Edizioni Internazionali Srl
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484929/ https://www.ncbi.nlm.nih.gov/pubmed/23440902 |
_version_ | 1782248208875913216 |
---|---|
author | Dohmen, P M |
author_facet | Dohmen, P M |
author_sort | Dohmen, P M |
collection | PubMed |
description | Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended durability, but permanent anticoagulation is mandatory. Tissue engineering created a new generation heart valve, which overcome limitations of biological and mechanical heart valves due to remodelling, regeneration and growth potential. Several publications are available in using tissue engineered heart valves in right ventricular outflow tract reconstruction. Limited experiences are available on these heart valves implanted into the systemic circulation. This overview shows the current state on the development of tissue engineered aortic heart valves. |
format | Online Article Text |
id | pubmed-3484929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | EDIMES Edizioni Internazionali Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-34849292013-02-25 Tissue engineered aortic valve Dohmen, P M HSR Proc Intensive Care Cardiovasc Anesth Brief-Report Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended durability, but permanent anticoagulation is mandatory. Tissue engineering created a new generation heart valve, which overcome limitations of biological and mechanical heart valves due to remodelling, regeneration and growth potential. Several publications are available in using tissue engineered heart valves in right ventricular outflow tract reconstruction. Limited experiences are available on these heart valves implanted into the systemic circulation. This overview shows the current state on the development of tissue engineered aortic heart valves. EDIMES Edizioni Internazionali Srl 2012 /pmc/articles/PMC3484929/ /pubmed/23440902 Text en Copyright © 2012, HSR Proceedings in Intensive Care and Cardiovascular Anesthesia http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License 3.0, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode. |
spellingShingle | Brief-Report Dohmen, P M Tissue engineered aortic valve |
title | Tissue engineered aortic valve |
title_full | Tissue engineered aortic valve |
title_fullStr | Tissue engineered aortic valve |
title_full_unstemmed | Tissue engineered aortic valve |
title_short | Tissue engineered aortic valve |
title_sort | tissue engineered aortic valve |
topic | Brief-Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484929/ https://www.ncbi.nlm.nih.gov/pubmed/23440902 |
work_keys_str_mv | AT dohmenpm tissueengineeredaorticvalve |